Allegheny County will pay $10,000 to a person who allegedly was denied access to methadone while incarcerated, even though the person had been prescribed it before being jailed.

That settlement is part of an agreement between the U.S. Department of Justice and the county that says that at the time the complainant was at the county jail, officials were only giving “methadone to individuals incarcerated at [the jail] if they were pregnant and were in methadone treatment prior to their incarceration.”

A Department of Justice investigation also found that, before October 2022, nonpregnant people were put through medically supervised withdrawal after they entered the jail if they were using methadone before they were incarcerated.

By not providing methadone access to those people, county officials were violating the Americans with Disabilities Act, the agreement states.

Advertise with us

“Allegheny County, like so much of the country, has been hit hard by the opioid epidemic,” Eric G. Olshan, U.S. attorney for the Western District of Pennsylvania, said in a statement. “This agreement ensures that effective [opioid use disorder] treatment will be available to those in Allegheny County who need it most.”

Experts say the settlement also could make the Allegheny County Jail a model for other correctional facilities in the state — if the guidelines are followed.

Methadone was the first medication approved by the Food and Drug Administration for the treatment of opioid use disorder. (Three medications are now FDA-approved.)

The jail currently does not prescribe methadone but has methadone continuation services through a third-party provider. Records from Allegheny County Jail Oversight Board meetings show an average of 43 people receive methadone continuation each month. Between Jan. 1, 2021, and Friday, there was a daily average of 1,729 people incarcerated at the jail or at alternative sites, according to county data.

Inmates can be at a high risk of a fatal overdose upon release because tolerance changes without access to medication for opioid use disorder or to illicit opioids. One study found that opioid overdose risk was 10 times higher for those incarcerated than for the general population.

Advertise with us

“Being able to initiate people onto buprenorphine or methadone when incarcerated … is one of the most effective measures we have right now for overdose prevention,” said Jordan Scott, digital advocacy and organizing coordinator for the Pennsylvania Harm Reduction Network.

“Many, many people who have an opioid use disorder are not on treatment,” said Jessica Merlin, a professor in the Division of General Internal Medicine at the University of Pittsburgh and an addiction medicine specialist. “People cycle oftentimes in and out of treatment, and they may very well land in jail when they are not on treatment. This should not play a role in whether they receive it.”

County jail officials said in a prepared statement that the jail provides certain medications, whether directly or through a third party, used to treat opioid use disorder “for anyone who is admitted to the facility that has a verified script from the last 30 days.” Those include methadone, suboxone, sublocade and subutex.

A December 2022 report conducted by the National Commission of Correctional Healthcare, or NCCHC, outlining an audit of the county jail also found that the facility had just one detox nurse on staff; the person worked business hours Monday through Friday, leaving those booked during nights or weekends with few options.

“Our review identified multiple patients whose detoxification was poorly managed,” the report stated.

Advertise with us

It was unclear Friday whether detox nurse staffing had increased since the report was released.

The NCCHC report also found errors in prescribing medication.

Kezia Taylor, an assistant U.S. attorney and signee of the agreement, referred all questions to Tamara Collier, a Justice Department spokeswoman. She could not be reached Friday.

The agreement with the Department of Justice lasts for three years. It requires county officials to implement policies and personnel training to ensure that prisoners receive proper medication for opioid use disorder, if needed. Trainers must be approved by the Justice Department and have knowledge of Title II of the Americans with Disabilities Act, according to the agreement.

County officials also are required to report any lawsuits, complaints, charges or other allegations of jail officials violating the ADA to the Justice Department within 14 days of receiving them.

Advertise with us

In recent years, many people attending Jail Oversight Board meetings have criticized health care conditions at the jail, noting that medication can sometimes take hours or even days to reach prisoners.

Critics of jail leadership also have complained about working conditions inside the facility, including for health care staff. John Kenstowicz, a member of the Pennsylvania Interfaith Impact Network who has a master’s degree in social work from the University of Pittsburgh, released a study earlier this year that showed morale among health care staffers was low.

An audit from the County Controller’s office released in August also showed that, by the end of 2022, there were several health care vacancies, in union and nonunion positions alike.

Mr. Kenstowicz said Friday that while the jail is providing medications and the Department of Justice investigation is a good sign, the central issue of short staffing is still critical.

“It’s great that the DOJ is mandating that these treatments will be provided, [but] the question is, are they going to have the staff to administer all this?” Mr. Kenstowicz said.

Advertise with us

Jail officials said the county has hired six of 10 substance use recovery nurses, who are scheduled to begin screening patients this month. A request for proposals for a methadone provider is also being finalized, they said, with the target of having the provider in place by October 2024.

Ms. Scott said there are a variety of ways to implement the requirements despite short-staffing.

Referring to her time working at the Lehigh Valley Intake Unit from 2016 to 2021, Ms. Scott said it had a contract with Northampton County Prison in which Lehigh conducted all of the prison’s drug and alcohol assessments.

Opioid settlement funds also could be mined to expand resources, she said.

“There’s so much more to getting a bill passed,” she said, stressing the need for DOJ enforcement of its rulings. “The ADA passed in 1991, and we’re still actively fighting for it to be enforced.”

Advertise with us

She said she hopes the Department of Justice holds other correctional facilities accountable in cases of denying lifesaving medication to prisoners.

Due to the changing drug supply and the fact that fentanyl remains much stronger than drugs people used recreationally in the past, it will be vital that staff receive adequate training for starting people on treatment options like bupenorphine, experts said.

Patients can enter withdrawal if too much bupenorphine is given, and there’s a delicate dosing balance that physicians follow to prevent this — typically by starting at a small dose and scaling up.

But that’s not a reason not to use buprenorphine, she said. It's crucial that institutions like jails provide multiple options to treat opioid use disorder, because everyone responds differently.

“Some people prefer methadone, they feel better, they don’t like the way Suboxone makes them feel. For others, Suboxone is a miracle drug,” she said. “It’s about flexibility and options, just like any other medical problem.”

Advertise with us

ACJ providing multiple medications for opioid use disorder, if implemented correctly, puts the facility in a position of modeling what such treatment in jails could look like.

“ACJ has the potential to serve as a roadmap,” said Ms. Scott. “It just depends on whether they become a roadmap of what to do or what not to do.”

Hanna Webster: hwebster@post-gazette.com 

Steve Bohnel: sbohnel@post-gazette.com